Our contribution to the best treatment outcome for patients goes beyond just providing innovative medicines. Amgen is also committed to the society through various charities. Every year, Amgen employees are given the opportunity to volunteer one working day a year for a charity of their choice. With this 'Impact Day', Amgen's employees are creating a significant impact in Breda and beyond.
We work together with various organizations, such as Stichting de Bredase Singelloop and we also organize fundraisers.
The power of vitality
At Amgen, vitality is a key priority—and we often link it to a good cause. We support employees in taking charge of their vitality, both at work and at home. Recurring annual highlights of our vitality program include the Bredase Singelloop and Amgen’s "Tour of Brabant" cycling event, which raises money for charitable causes. Other initiatives, like Walk2Wellness—a yearly event encouraging employees to get moving—and access to AmGym, our on-site fitness facility, help motivate many colleagues to stay active and engaged.
Related stories
By selecting the Yes option, leaving Amgen.nl option you understand that you are leaving the corporate page of Amgen nl and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen nl is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in nl. If You reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.
By selecting the Yes option, leaving Amgen.nl option you understand that you are leaving the corporate page of Amgen nl and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen nl is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in nl. If You reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.